Nasus Pharma Ltd.

NSRX | AMEX

Price Alert Chart Builder DCF Calculator

$3.16

-$0.15 (-4.53%)

At close: Oct 30, 2026, 3:59 PM ET

$3.16

$0.00 (0.00%)

After-hours: Oct 30, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q4 2024 Dec 31, 2024	Q2 2024 Jun 30, 2024
Cash & Equivalents	7.82M	7.82M	1.24M	1.24M	284K	900K
Short-Term Investments	4M	4M	3.05M	3.05M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	260K	91K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	86K	86K	240K	240K	173K	29K
Total Current Assets	12.31M	12.31M	4.86M	4.86M	457K	929K
Property-Plant & Equipment	138K	138K	149K	149K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	138K	138K	149K	149K	260K	91K
Total Assets	12.45M	12.45M	5M	5M	717K	1.02M
Account Payables	347K	347K	829K	829K	651K	652K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	1.8M	3.8M
Other Current Liabilities	435K	435K	736K	503K	489K	492K
Total Current Liabilities	1.4M	1.4M	2.16M	2.16M	3.93M	5.68M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	49K	49K	73K	73K	n/a	n/a
Total Liabilities	1.45M	1.45M	2.24M	2.24M	3.93M	5.68M
Total Debt	103K	103K	118K	118K	1.8M	3.8M
Book Value	11M	11M	2.77M	2.77M	-3.21M	-4.66M
Book Value Per Share	0.99	0.99	0.31	0.38	-0.44	-0.65
Common Stock	n/a	n/a	n/a	n/a	20K	4K
Retained Earnings	-24.46M	-24.46M	-18.52M	-18.52M	-12.66M	-12M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	11M	11M	2.77M	2.77M	-3.21M	-4.66M
Total Investments	4M	4M	3.05M	3.05M	n/a	n/a